Articles On Creso Pharma (ASX:CPH)

Today Creso Pharma (ASX: CPH) reported new and follow up Purchase Orders for its animal health medicinal cannabis products totalling over A$345,000.

The Creso Pharma Ltd (ASX: CPH) share price is on the move on Tuesday morning following the release an update. At the time of writing, the cannabis company’s shares are up 16% to 25.5 cents. What did Creso Pharma announce? This morning Cre...

Creso Pharma Limited (ASX:CPH; FRA:1X8) continues to build a strong revenue platform for 2021, advising today that it has received two new purchase orders (POs) for its anibidiol® line of animal health products totalling A$247,826 (CHF171,0...

Special Report: Creso Pharma (ASX:CPH) says it has filled two more purchase orders for its anibidiol  animal health products, confirming ... Read More The post Creso Pharma experiencing strong demand for pet-health cannabis products appeare...

–The below is a company-sponsored announcement– Growing revenues put Creso Pharma in the box seat to capitalise on positive cannabis momentum Listed cannabis company Creso Pharma Ltd. ((CPH)) looks to have started 2021 as it finished 2020...

Summary Nedlands-headquartered Creso Pharma delivers the 2nd shipment of its cannaQIX® products to Pharma Dynamics in South Africa. With a second purchase order (PO) and delivery, Creso adds A$320K to its growing revenue. The cannabis...

In morning trade the Creso Pharma Ltd (ASX: CPH) share price is storming higher following the release of an announcement. At the time of writing, the cannabis company’s shares are up 13% to 26 cents. What did Creso Pharma announce? This mo...

Delivery of the second purchase order follows the company’s successful launch into the South African market in collaboration with Pharma Dynamics. 

Special Report: The company’s latest purchase order for its cannaQIX cannabis lozenges adds to what is now a rapidly expanding ... Read More The post Creso Pharma books another cannaQIX order in South Africa, as cash stockpile soars appeare...

Creso Pharma Limited (ASX:CPH; FRA: 1X8) has completed all required importing and exporting procedures and successfully delivered a second shipment of cannaQIX® products to the subsidiary of Lupin International (NYSE:LUPIN), Pharma Dynamics...

ASX shares related to sustainable energy aren’t the only green companies likely to get a boost from the blue wave that swept through the US elections. ASX cannabis companies could also receive some fresh tailwinds. How the Georgia election...

EDITOR’S NOTE: It’s Greg Canavan, Editorial Director, here. I sent the following essay out to all subscribers of Port Phillip Publishing and Fat Tail Media products at the end of last year. It’s Part I of a two-part review of the performanc...

Summary US Democratic Party has secured the balance of power in US Senate. Thus, increased the chances of legalisation of cannabis and the approval of the MORE Act. The MORE Act seeks to eliminate cannabis from the US Controlled Substa...

The US Democratic Party has secured the balance of power in US Senate which increases the likelihood of cannabis policy reform and the decriminalisation of cannabis in the country.

In late morning trade the S&P/ASX 200 Index (ASX: XJO) has given back some of its early gains but is still trading higher. At the time of writing, the benchmark index is up 0.2% to 6,723.1 points. Four shares that are climbing more tha...

Creso Pharma Limited (ASX:CPH; FRA: 1X8) was among the myriad of cannabis stocks to surge on Thursday (07/01/2021) following early news from the United States that the Democrats had taken control of the Senate. Following significant share p...

08 Jan 2021 - Medicinal cannabis company, Creso Pharma (ASX:CPH) says that there is a significantly increased likelihood of cannabis reform in the US now that the Democrats have o…

The market may have surged higher on Thursday but that was nothing compared to the gain made by the Creso Pharma Ltd (ASX: CPH) share price. The cannabis company’s shares rocketed a whopping 47% higher to 26 cents. Why did the Creso Pharma...

Summary The Australian cannabis industry welcomed TGA’s recent decision to down schedule cannabidiol. The regulatory body’s decision will come into effect from 1 February 2021, instead of 1 June 2021 set earlier. Most of the ASX-liste...

While most ASX companies already have products sold in the market and have built sales traction, there are also companies that are still preparing for market launch. Here I’ve listed down three ASX small cap companies that are preparing to...

Feedback from end-users and resellers is that initial orders will occur immediately upon Mernova’s launch into hash.

Summary Creso Pharma has obtained regulatory approval for delivering its animal health product line, anibidiol® in Uruguay. Anibidiol® is now the first hemp oil-based product line to be provided for pets in the Latin American region....

Special Report: Creso Pharma’s (ASX:CPH)’s commercial partner has received its first Latin American purchase order for its hemp oil product ... Read More The post Creso Pharma receives first pet-health cannabis orders in Latin America appea...

The company expects first purchase order for anibidiol® 8 to be delivered in the first quarter of 2021, becoming the first approved CBD hemp-based complementary feed for pets in Latin America. 

Creso Pharma Limited (ASX:CPH, FRA: 1X8) has secured regulatory approval from the Ministry of Agriculture and Animal Feed in Uruguay (Ministerio de Ganadaria, Agricultura y Pesca) through its commercial partner Adler Laboratories, Uruguay f...

Of ASX cannabis shares, Creso Pharma Ltd (ASX: CPH) shares have taken the spotlight recently after running more than 300% this month. Today, however, at the time of writing, the Creso share price has fallen 4.17% to 23 cents. This comes de...

Special Report: Creso Pharma’s (ASX:CPH)’s wholly-owned Canadian subsidiary, Mernova Medicinal, has been recognised as a supplier to the Ontario Cannabis ... Read More The post Creso Pharma expands into Canada’s largest cannabis market appe...

Summary Medicinal cannabis player Creso Pharma has entered into a supply agreement to provide its products in Canadian cannabis market. The agreement allows Creso to sell its three cannabis strains in Canada. Creso Pharma expects robu...

This new supply agreement further demonstrates Mernova’s strong foothold in Canada and the ability to service the Canadian market.

In a highly promising commercial development, Creso Pharma Limited’s (ASX:CPH) wholly-owned Canadian subsidiary, Mernova Medicinal Inc. has secured an agreement with the Ontario Cannabis Retail Corporation (OCRC), operating as the Ontario C...

Special Report: Creso Pharma’s low dosage cannabidiol (CBD) products will soon be available over the counter at Australian pharmacies after ... Read More The post Creso Pharma’s CBD medicines will be available prescription free in Australia...

Creso Pharma Limited (ASX:CPH; FRA: 1X8) is positioned to significantly benefit from a decision today by the Therapeutic Goods Administration (TGA) to down-schedule low dose cannabidiol (CBD) preparations from Schedule 4 (Prescription Medic...

Creso Pharma is well-positioned to respond quickly to this favourable decision, with existing CBD products ready to ship to the Australian market.

Mernova Medicinal Inc., a wholly owned subsidiary of Creso Pharma (ASX: CPH), received three purchase orders last week with a combined value of over $288,000.

Marijuana companies – or “pot stocks” to those who prefer brevity – were all the rage back in late 2017 and early 2018. California, America’s most populous state and the fifth largest economy in the world, was legalising the recreational u...

Summary The intensity of adoption of tech-enabled health solutions has shot up amidst government restrictions and infection risks amidst COVID-19. Burgeoning demand for healthcare products kept healthcare stocks under the spotlight in...

The non-binding agreement provides Creso Pharma with a framework to respond quickly to a favourable TGA final decision due in the coming weeks to down schedule CBD products in Australia.

Special Report: Creso Pharma’s (ASX:CPH) has signed a deal to supply its products to an Australian supplier, if the Therapeutic ... Read More The post Creso Pharma signs deal with natural lifestyle brand supplier Martin & Pleasance appe...

Creso Pharma Limited (ASX:CPH, FRA: 1X8) has today obtained an exclusive Heads of Agreement (HOA) with leading natural, sustainable health and lifestyle brand supplier Martin & Pleasance Pty Ltd. The agreement could see Creso Pharma cap...

The Creso Pharma Ltd (ASX: CPH) share price is on course to end its remarkable run on Thursday with a sizeable decline. The cannabis company’s shares were down as much as 33% at one stage to 20 cents this afternoon. The Creso Pharma share...

Last week, Zip Co Ltd (ASX: Z1P) shares were the most traded on the ASX, just ahead of Creso Pharma Ltd (ASX: CPH) and Treasury Wine Estates Ltd (ASX: TWE). Interestingly, buyers accounted for roughly 70% of trades, so it seems that some AS...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a great month for the ASX ... Read More The post Check Up: Creso Pharma gets really, really high; leads ASX health sector appeared first on Stockhead.

Creso Pharma Ltd (ASX: CPH) was the second most-traded share on the ASX last week by CommSec clients. Two weeks ago, the Creso Pharma share price was trading at around 3 cents, but has since shot up to 33 cents at the time of writing. Creso...

Special Report: Creso Pharma’s (ASX:CPH) wholly-owned Canadian subsidiary, Mernova Medicinal, has received more purchase orders for strains of its high-quality ... Read More The post Creso Pharma subsidiary expands into Canada’s biggest rec...

Medicinal cannabis company Creso Pharma (ASX: CPH) has been riding the wave of loosening regulations relating to cannabis, with company also revealing it has expanded into Canada’s largest recreational market. Today’s move into Canada’s lar...

The Creso Pharma Ltd (ASX: CPH) share price has continued its remarkable run on Wednesday. At the time of writing, the cannabis company’s shares are up a massive 96% to a 52-week high of 46 cents. This means the Creso Pharma share price ha...

Summary Creso Pharma forays into Canada’s largest recreational market; secures three purchase orders. The three purchase orders open potential new opportunities for the Company in new Canadian markets. The total value of the three pur...

The orders open potential new opportunities for new Canadian markets in Ontario and the Yukon, which recorded combined sales for recreational cannabis of more than C$300 million for 2020.

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.65% to 6,731.2 points. Four shares that are climbing more than most today are listed below....

Creso Pharma Limited (ASX:CPH; FRA: 1X8) continues to build on a fortnight of strong news flow with its wholly-owned Canadian subsidiary, Mernova Medicinal Inc. receiving three purchase orders with a combined value of C$275,023 (A$288,159)....